Screening | Who needs it | How often |
|---|
Alcohol misuse | All adults | At routine exams |
Blood pressure | All adults | Yearly checkup if your blood pressure is normal* Normal blood pressure is less than 120/80 mm Hg* If your blood pressure reading is higher than normal, follow the advice of your healthcare provider |
Depression | All men in this age group | At routine exams |
Type 2 diabetes or prediabetes | All men beginning at age 45 and men without symptoms at any age who are overweight or obese and have 1 or more additional risk factors for diabetes | At least every 3 years (annually if blood sugar is already rising) |
Type 2 diabetes | All men with prediabetes | Every year |
Hepatitis C | Anyone at increased risk | At routine exams |
HIV | All men | At routine exams |
High cholesterol and triglycerides | All men ages 35 and older, and younger men at high risk for coronary artery disease | At least every 5 years |
Obesity | All adults | At routine exams |
Prostate cancer | Starting at age 45, talk to healthcare provider about risks and benefits of digital rectal exam (DRE) and prostate-specific antigen (PSA) screening*** | At routine exams |
Colorectal cancer | Men of average risk ages 45 and older | Several tests are available and used at different times. Tests include: Flexible sigmoidoscopy every 5 years, or CT colonography (virtual colonoscopy) every 5 years, or Colonoscopy every 10 years, or Yearly fecal occult blood test, or Yearly fecal immunochemical test every year, or Stool DNA test, every 3 years
You will need a follow-up colonoscopy if you choose any test other than a colonoscopy and you have an abnormal result. Screening recommendations vary among expert groups. Talk with your doctor about which test is best for you. Some people should be screened using a different schedule because of their personal or family history. Talk with your doctor about your health history and what colorectal cancer screening schedule is best for you. |
Syphilis | Anyone at increased risk for infection | At routine exams |
Tuberculosis | Anyone at increased risk for infection | Check with your healthcare provider |
Vision | All adults1 | Every 2 to 4 years if no risk factors for eye disease |
Counseling | Who needs it | How often |
|---|
Diet and exercise, | Adults who are overweight or obese | When diagnosed and at routine exams |
Aspirin for primary prevention of cardiovascular problems | Men ages 45 to 79, when potential benefits from a decrease in heart attacks outweigh the harm or risks from an increase in gastrointestinal hemorrhage | When diagnosed with risk for cardiovascular/heart disease; check with your healthcare provider before starting |
Sexually transmitted infection prevention | Anyone at increased risk for infection | At routine exams |
Tobacco use and tobacco-related disease | All adults | Every exam |
Immunization | Who needs it | How often |
|---|
Tetanus/diphtheria/
pertussis (Td/Tdap) booster | All adults | Td: every 10 years Tdap: substitute a 1-time dose of Tdap for a Td booster after age 18, then boost with Td every 10 years |
Measles, mumps, rubella (MMR) | All adults in this age group who have no record of previous infection or vaccines** | 1 or 2 doses |
Chickenpox (varicella) | All adults in this age group who have no record of previous infection or vaccines** | 2 doses; the second dose should be given at least 4 weeks after the first dose |
Flu (seasonal) | All adults | Yearly, when the vaccine becomes available in the community |
Hepatitis A | People at risk2 | 2 doses given at least 6 months apart |
Hepatitis B | People at risk3 | 3 doses; the second dose should be given 1 month after the first dose, and the third dose should be given at least 2 months after the second dose (or at least 4 months after the first dose) |
Haemophilus influenza Type B (HIB) | People at risk | 1 to 3 doses |
Meningococcal | People at risk** | 1 or more doses |
Pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23) | People at risk4 | PCV13: 1 dose ages 19 to 65 (protects against 13 types of pneumococcal bacteria) PPSV23: 1 to 2 doses through age 64, or 1 dose at 65 or older (protects against 23 types of pneumococcal bacteria) |